Akt/PKB: One kinase, many modifications

Biochemical Journal

Volumn 468, Issue 2, 2015, Pages 203-214

  Risso, Guillermo ^a   Blaustein, Matías ^a   Pozzi, Berta ^a   Mammi, Pablo ^a   Srebrow, Anabella ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

Author keywords

Akt; Post translational modification; Protein function; Protein kinase B; Signal transduction

Indexed keywords

CYSTEINE; DEUBIQUITINASE; LYSINE; PROTEIN KINASE B; SERINE; THREONINE; TYROSINE;

AMINO ACID SEQUENCE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; UBIQUITINATION; ANIMAL; METABOLISM;

EUKARYOTA;

ANIMALS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84934903117     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20150041     Document Type: Review

References (96)

1. Clark, A.R. and Toker, A. (2014) Signalling specificity in the Akt pathway in breast cancer. Biochem. Soc. Trans. 42, 1349-1355 CrossRef PubMed
2. Cheung, M. and Testa, J.R. (2013) Diverse mechanisms of AKT pathway activation in human malignancy. Curr. Cancer Drug Targets 13, 234-244 CrossRef PubMed
3. Altomare, D.A. and Testa, J.R. (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455-7464 CrossRef PubMed
4. Bellacosa, A., Kumar, C.C., Di Cristofano, A. and Testa, J.R. (2005) Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 94, 29-86 CrossRef PubMed
5. Hers, I., Vincent, E.E. and Tavar é, J.M. (2011) Akt signalling in health and disease. Cell. Signal. 23, 1515-1527 CrossRef PubMed
6. Manning, B.D. and Cantley, L.C. (2007) AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274 CrossRef PubMed
7. Santi, S.A. and Lee, H. (2010) The Akt isoforms are present at distinct subcellular locations. Am. J. Physiol. Cell Physiol. 298, C580-C591 CrossRef PubMed
8. Mahajan, K. and Mahajan, N.P. (2012) PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics. J. Cell. Physiol. 227, 3178-3184 CrossRef PubMed
9. Hanada, M., Feng, J. and Hemmings, B.A. (2004) Structure, regulation and function of PKB/AKT: a major therapeutic target. Biochim. Biophys. Acta 1697, 3-16 CrossRef PubMed
10. Huber, M., Helgason, C.D., Damen, J.E., Scheid, M., Duronio, V., Liu, L., Ware, M.D., Humphries, R.K. and Krystal, G. (1999) The role of SHIP in growth factor induced signalling. Prog. Biophys. Mol. Biol. 71, 423-434 CrossRef PubMed
11. Rohrschneider, L.R., Fuller, J.F., Wolf, I., Liu, Y. and Lucas, D.M. (2000) Structure, function, and biology of SHIP proteins. Genes Dev. 14, 505-520 PubMed
12. Gao, T., Furnari, F. and Newton, A.C. (2005) PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13-24 CrossRef PubMed
13. Andjelkovic, M., Jakubowicz, T., Cron, P., Ming, X.F., Han, J.W. and Hemmings, B.A. (1996) Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 93, 5699-5704 CrossRef PubMed
14. Alessi, D.R., Deak, M., Casamayor, A., Caudwell, F.B., Morrice, N., Norman, D.G., Gaffney, P., Reese, C.B., MacDougall, C.N., Harbison, D. et al. (1997) 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7, 776-789 CrossRef PubMed
15. Sarbassov, D.D., Guertin, D.A., Ali, S.M. and Sabatini, D.M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 CrossRef PubMed
16. Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B.A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551 PubMed
17. Liao, Y. and Hung, M.C. (2010) Physiological regulation of Akt activity and stability. Am. J. Transl. Res. 2, 19-42 PubMed
18. Kohn, A.D., Takeuchi, F. and Roth, R.A. (1996) Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271, 21920-21926 CrossRef PubMed
19. Bellacosa, A., Chan, T.O., Ahmed, N.N., Datta, K., Malstrom, S., Stokoe, D., McCormick, F., Feng, J. and Tsichlis, P. (1998) Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17, 313-325 CrossRef PubMed
20. Liao, Y., Wei, Y., Zhou, X., Yang, J.-Y., Dai, C., Chen, Y.-J., Agarwal, N.K., Sarbassov, D., Shi, D., Yu, D. et al. (2009) Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene 28, 2436-2445 CrossRef PubMed
21. Conus, N.M., Hannan, K.M., Cristiano, B.E., Hemmings, B.A. and Pearson, R.B. (2002) Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J. Biol. Chem. 277, 38021-38028 CrossRef PubMed
22. Di Maira, G., Salvi, M., Arrigoni, G., Marin, O., Sarno, S., Brustolon, F., Pinna, L.A. and Ruzzene, M. (2005) Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Cell Death Differ. 12, 668-677 CrossRef PubMed
23. Di Maira, G., Brustolon, F., Pinna, L.A. and Ruzzene, M. (2009) Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells. Cell. Mol. Life Sci. 66, 3363-3373 CrossRef PubMed
24. Gulen, M.F., Bulek, K., Xiao, H., Yu, M., Gao, J., Sun, L., Beurel, E., Kaidanovich-Beilin, O., Fox, P.L., DiCorleto, P.E. et al. (2012) Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance. Immunity 37, 800-812 CrossRef PubMed
25. Chan, T.O., Rittenhouse, S.E. and Tsichlis, P.N. (1999) AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68, 965-1014 CrossRef PubMed
26. Chan, T.O. and Tsichlis, P.N. (2001) PDK2: a complex tail in one Akt. Sci. STKE 2001, pe1 PubMed
27. Alessi, D.R., Pearce, L.R. and García-Martínez, J.M. (2009) New insights into mTOR signaling: mTORC2 and beyond. Sci. Signal. 2, pe27 CrossRef PubMed
28. Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. and Guan, K.-L. (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919-1931 CrossRef PubMed
29. Facchinetti, V., Ouyang, W., Wei, H., Soto, N., Lazorchak, A., Gould, C., Lowry, C., Newton, A.C., Mao, Y., Miao, R.Q. et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27, 1932-1943 CrossRef PubMed
30. Oh, W.J., Wu, C.C., Kim, S.J., Facchinetti, V., Julien, L.A., Finlan, M., Roux, P.P., Su, B. and Jacinto, E. (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 29, 3939-3951 CrossRef PubMed
31. Shao, Z., Bhattacharya, K., Hsich, E., Park, L., Walters, B., Germann, U., Wang, Y.M., Kyriakis, J., Mohanlal, R., Kuida, K. et al. (2006) c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ. Res. 98, 111-118 CrossRef PubMed
32. Wei, J., Wang, W., Chopra, I., Li, H.F., Dougherty, C.J., Adi, J., Adi, N., Wang, H. and Webster, K.A. (2011) c-Jun N-terminal kinase (JNK-1) confers protection against brief but not extended ischemia during acute myocardial infarction. J. Biol. Chem. 286, 13995-14006 CrossRef PubMed
33. Liu, P., Begley, M., Michowski, W., Inuzuka, H., Ginzberg, M., Gao, D., Tsou, P., Gan, W., Papa, A., Kim, B.M. et al. (2014) Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 508, 541-545 CrossRef PubMed
34. Liu, P., Wang, Z. and Wei, W. (2014) Phosphorylation of Akt at the C-terminal tail triggers Akt activation. Cell Cycle 13, 2162-2164 CrossRef PubMed
35. Mahajan, K., Coppola, D., Challa, S., Fang, B., Chen, Y.A., Zhu, W., Lopez, A.S., Koomen, J., Engelman, R.W., Rivera, C. et al. (2010) Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS ONE 5, e9646 CrossRef PubMed
36. Datta, K., Bellacosaf, A., Chan, T.O. and Tsichlis, P.N. (1996) Akt is a direct target of the phosphatidylinositol 3-kinase: Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J. Biol. Chem. 271, 30835-30839 CrossRef PubMed
37. Wong, B.R., Besser, D., Kim, N., Arron, J.R., Vologodskaia, M., Hanafusa, H. and Choi, Y. (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 4, 1041-1049
38. Chen, R., Kim, O., Yang, J., Sato, K., Eisenmann, K.M., McCarthy, J., Chen, H. and Qiu, Y. (2001) Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276, 31858-31862 CrossRef PubMed
39. Jiang, T. and Qiu, Y. (2003) Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J. Biol. Chem. 278, 15789-15793 CrossRef PubMed
40. Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J. and Pei, G. (2009) Deficiency of a β -arrestin-2 signal complex contributes to insulin resistance. Nature 457, 1146-1149 CrossRef PubMed
41. Zheng, Y., Peng, M., Wang, Z., Asara, J.M. and Tyner, A.L. (2010) Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor. Mol. Cell. Biol. 30, 4280-4292 CrossRef PubMed
42. Balendran, A., Casamayor, A., Deak, M., Paterson, A., Gaffney, P., Currie, R., Downes, C.P. and Alessi, D.R. (1999) PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 9, 393-404 CrossRef PubMed
43. Guo, J.P., Coppola, D. and Cheng, J.Q. (2011) IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. J. Biol. Chem. 286, 37389-37398 CrossRef PubMed
44. Joung, S.M., Park, Z.-Y., Rani, S., Takeuchi, O., Akira, S. and Lee, J.Y. (2011) Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1. J. Immunol. 186, 499-507 CrossRef PubMed
45. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M.L., Rehman, M., Walther, T.C., Olsen, J.V. and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840 CrossRef PubMed
46. Milne, J.C., Lambert, P.D., Schenk, S., Carney, D.P., Smith, J.J., Gagne, D.J., Jin, L., Boss, O., Perni, R.B., Vu, C.B. et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716 CrossRef PubMed
47. Sundaresan, N.R., Pillai, V.B., Wolfgeher, D., Samant, S., Vasudevan, P., Parekh, V., Raghuraman, H., Cunningham, J.M., Gupta, M. and Gupta, M.P. (2011) The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci. Signal. 4, ra46 CrossRef PubMed
48. Chung, H.S., Wang, S.-B., Venkatraman, V., Murray, C.I. and Van Eyk, J.E. (2013) Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ. Res. 112, 382-392 CrossRef PubMed
49. Finkel, T. (2011) Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15 CrossRef PubMed
50. Wani, R., Qian, J., Yin, L., Bechtold, E., King, S.B., Poole, L.B., Paek, E., Tsang, A.W. and Furdui, C.M. (2011) Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 108, 10550-10555 CrossRef PubMed
51. Wani, R., Bharathi, N.S., Field, J., Tsang, A.W. and Furdui, C.M. (2011) Oxidation of Akt2 kinase promotes cell migration and regulates G1 -S transition in the cell cycle. Cell Cycle 10, 3263-3268 CrossRef PubMed
52. Hart, G.W., Slawson, C., Ramirez-Correa, G. and Lagerlof, O. (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80, 825-858 CrossRef PubMed
53. Zeidan, Q. and Hart, G.W. (2010) The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J. Cell Sci. 123, 13-22 CrossRef PubMed
54. Park, S.Y., Ryu, J. and Lee, W. (2005) O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Exp. Mol. Med. 37, 220-229 CrossRef PubMed
55. Gandy, J.C., Rountree, A.E. and Bijur, G.N. (2006) Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1. FEBS Lett. 580, 3051-3058 CrossRef PubMed
56. Whelan, S.A., Lane, M.D. and Hart, G.W. (2008) Regulation of the O-linked β -N-acetylglucosamine transferase by insulin signaling. J. Biol. Chem. 283, 21411-21417 CrossRef PubMed
57. Ball, L.E., Berkaw, M.N. and Buse, M.G. (2006) Identification of the major site of O-linked β -N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol. Cell. Proteomics 5, 313-323 CrossRef PubMed
58. Klein, A.L., Berkaw, M.N., Buse, M.G. and Ball, L.E. (2009) O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs. Mol. Cell. Proteomics 8, 2733-2745 CrossRef PubMed
59. Vosseller, K., Wells, L., Lane, M.D. and Hart, G.W. (2002) Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. U.S.A. 99, 5313-5318 CrossRef PubMed
60. Yang, X., Ongusaha, P.P., Miles, P.D., Havstad, J.C., Zhang, F., So, W.V., Kudlow, J.E., Michell, R.H., Olefsky, J.M., Field, S.J. et al. (2008) Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451, 964-969 CrossRef PubMed
61. Wang, S., Huang, X., Sun, D., Xin, X., Pan, Q., Peng, S., Liang, Z., Luo, C., Yang, Y., Jiang, H. et al. (2012) Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling. PLoS ONE 7, e37427 CrossRef PubMed
62. Kang, E.-S., Han, D., Park, J., Kwak, T.K., Oh, M.-A., Lee, S.-A., Choi, S., Park, Z.Y., Kim, Y. and Lee, J.W. (2008) O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic β cells. Exp. Cell Res. 314, 2238-2248 CrossRef PubMed
63. Heath, J.M., Sun, Y., Yuan, K., Bradley, W.E., Litovsky, S., Dell'Italia, L.J., Chatham, J.C., Wu, H. and Chen, Y. (2014) Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus. Circ. Res. 114, 1094-1102 CrossRef PubMed
64. Finley, D. (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477-513 CrossRef PubMed
65. Basso, A.D., Solit, D.B., Chiosis, G., Giri, B., Tsichlis, P. and Rosen, N. (2002) Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 277, 39858-39866 CrossRef PubMed
66. Xiang, T., Ohashi, A., Huang, Y., Pandita, T.K., Ludwig, T., Powell, S.N. and Yang, Q. (2008) Negative regulation of AKT activation by BRCA1. Cancer Res. 68, 10040-10044 CrossRef PubMed
67. Dickey, C.A., Koren, J., Zhang, Y.-J., Xu, Y.-F., Jinwal, U.K., Birnbaum, M.J., Monks, B., Sun, M., Cheng, J.Q., Patterson, C. et al. (2008) Akt and CHIP coregulate tau degradation through coordinated interactions. Proc. Natl. Acad. Sci. U.S.A. 105, 3622-3627 CrossRef PubMed
68. Su, C.H., Wang, C.Y., Lan, K.H., Li, C.P., Chao, Y., Lin, H.C., Lee, S.D. and Lee, W.P. (2011) Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiquitination of the kinase. Cell. Signal. 23, 1824-1830 CrossRef PubMed
69. Suizu, F., Hiramuki, Y., Okumura, F., Matsuda, M., Okumura, A.J., Hirata, N., Narita, M., Kohno, T., Yokota, J., Bohgaki, M. et al. (2009) The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. Dev. Cell 17, 800-810 CrossRef PubMed
70. Bae, S., Kim, S.Y., Jung, J.H., Yoon, Y., Cha, H.J., Lee, H., Kim, K., Kim, J., An, I.S., Um, H.D. et al. (2012) Akt is negatively regulated by the MULAN E3 ligase. Cell Res. 22, 873-885 CrossRef PubMed
71. Yang, W.-L., Wang, J., Chan, C.-H., Lee, S.-W., Campos, A.D., Lamothe, B., Hur, L., Grabiner, B.C., Lin, X., Darnay, B.G. et al. (2009) The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134-1138 CrossRef PubMed
72. Chan, C.H., Li, C.F., Yang, W.L., Gao, Y., Lee, S.W., Feng, Z., Huang, H.Y., Tsai, K.K., Flores, L.G., Shao, Y. et al. (2012) The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149, 1098-1111 CrossRef PubMed
73. Fan, C.-D., Lum, M.A., Xu, C., Black, J.D. and Wang, X. (2013) Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, NEDD4-1, in the insulin-like growth factor-1 response. J. Biol. Chem. 288, 1674-1684 CrossRef PubMed
74. Lim, J.H., Jono, H., Komatsu, K., Woo, C.-H., Lee, J., Miyata, M., Matsuno, T., Xu, X., Huang, Y., Zhang, W. et al. (2012) CYLD negatively regulates transforming growth factor-β -signalling via deubiquitinating Akt. Nat. Commun. 3, 771 CrossRef PubMed
75. Yang, W.-L., Jin, G., Li, C.-F., Jeong, Y.S., Moten, A., Xu, D., Feng, Z., Chen, W., Cai, Z., Darnay, B. et al. (2013) Cycles of ubiquitination and deubiquitination critically regulate growth factor-mediated activation of Akt signaling. Sci. Signal. 6, ra3 PubMed
76. Geiss-Friedlander, R. and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956 CrossRef PubMed
77. Bernassola, F., Karin, M., Ciechanover, A. and Melino, G. (2008) The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14, 10-21 CrossRef PubMed
78. Deshaies, R.J. and Joazeiro, C.A. (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434 CrossRef PubMed
79. Li, R., Wei, J., Jiang, C., Liu, D., Deng, L., Zhang, K. and Wang, P. (2013) Akt SUMOylation regulates cell proliferation and tumorigenesis. Cancer Res. 73, 5742-5753 CrossRef PubMed
80. Risso, G., Pelisch, F., Pozzi, B., Mammi, P., Blaustein, M., Colman-Lerner, A. and Srebrow, A. (2013) Modification of Akt by SUMO conjugation regulates alternative splicing and cell cycle. Cell Cycle 12, 3165-3174 CrossRef PubMed
81. Hendriks, I.A., D'Souza, R. C. J., Yang, B., Verlaan-de Vries, M., Mann, M. and Vertegaal, A.C.O. (2014) Uncovering global SUMOylation signaling networks in a site-specific manner. Nat. Struct. Mol. Biol. 21, 927-936 CrossRef PubMed
82. de la Cruz-Herrera, C.F., Campagna, M., Lang, V., Del Carmen Gonz ález-Santamaría, J., Marcos-Villar, L., Rodríguez, M.S., Vidal, A., Collado, M. and Rivas, C. (2014) SUMOylation regulates AKT1 activity. Oncogene 34, 1-9 PubMed
83. Huang, J., Yan, J., Zhang, J., Zhu, S., Wang, Y., Shi, T., Zhu, C., Chen, C., Liu, X., Cheng, J. et al. (2012) SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Nat. Commun. 3, 911 CrossRef PubMed
84. Bassi, C., Ho, J., Srikumar, T., Dowling, R.J.O., Gorrini, C., Miller, S.J., Mak, T.W., Neel, B.G., Raught, B. and Stambolic, V. (2013) Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 341, 395-399 CrossRef PubMed
85. Gonzalez-Santamaria, J., Campagna, M., Ortega-Molina, A., Marcos-Villar, L., de la Cruz-Herrera, C.F., Gonzalez, D., Gallego, P., Lopitz-Otsoa, F., Esteban, M., Rodriguez, M.S. et al. (2012) Regulation of the tumor suppressor PTEN by SUMO. Cell Death Dis. 3, e393 CrossRef PubMed
86. Psakhye, I. and Jentsch, S. (2012) Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair. Cell 151, 807-820 CrossRef PubMed
87. Flotho, A. and Melchior, F. (2013) Sumoylation: a regulatory protein modification in health and disease. Annu. Rev. Biochem. 82, 357-385 CrossRef PubMed
88. Chen, J.-Y., Lin, J.-R., Cimprich, K.A. and Meyer, T. (2012) A two-dimensional ERK-AKT signaling code for an NGF-triggered cell-fate decision. Mol. Cell 45, 196-209 CrossRef PubMed
89. Hosoi, T., Hyoda, K., Okuma, Y., Nomura, Y. and Ozawa, K. (2007) Akt up- and down-regulation in response to endoplasmic reticulum stress. Brain Res. 1152, 27-31 CrossRef PubMed
90. Mounir, Z., Krishnamoorthy, J.L., Wang, S., Papadopoulou, B., Campbell, S., Muller, W.J., Hatzoglou, M. and Koromilas, A.E. (2011) Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway. Sci. Signal. 4, ra62 CrossRef PubMed
91. Blaustein, M., P érez-Munizaga, D., S ánchez, M.A., Urrutia, C., Grande, A., Risso, G., Srebrow, A., Alfaro, J. and Colman-Lerner, A. (2013) Modulation of the Akt pathway reveals a novel link with PERK/eIF2α, which is relevant during hypoxia. PLoS ONE 8, e69668 CrossRef PubMed
92. Rajesh, K., Krishnamoorthy, J., Kazimierczak, U., Tenkerian, C., Papadakis, A.I., Wang, S., Huang, S. and Koromilas, A.E. (2015) Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stress. Cell Death Dis. 6, e1591 CrossRef PubMed
93. Shaw, J. and Kirshenbaum, L.A. (2006) Prime time for JNK-mediated Akt reactivation in hypoxia-reoxygenation. Circ. Res. 98, 7-9 CrossRef PubMed
94. Singh, D.K., Ku, C.-J., Wichaidit, C., Steininger, R.J., Wu, L.F. and Altschuler, S.J. (2010) Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities. Mol. Syst. Biol. 6, 369 CrossRef PubMed
95. Purvis, J.E. and Lahav, G. (2013) Encoding and decoding cellular information through signaling dynamics. Cell 152, 945-56 CrossRef PubMed
96. Lin, C.H., Liu, S.Y. and Lee, E.H. (2015) SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1. Oncogene CrossRef